Literature DB >> 7502524

Therapeutic applications of vagotomy.

L Olbe1.   

Abstract

The treatment of the peptic ulcer disease involves several options. The present discussion deals with the long-term management with emphasis on the application of vagotomy. Eradication of Helicobacter pylori is the treatment of choice in ordinary peptic ulcer patients. Exceptions are non-steroidal, anti-inflammatory drug-induced ulcers and the Zollinger-Ellison syndrome. Failures to eradicate H. pylori in old or unfit duodenal ulcer patients and most gastric ulcer patients will lead to intermittent antisecretory treatment or continuous maintenance treatment. Maintenance treatment will usually mean lifelong treatment, and optimal results are probably obtained with a full-dose antisecretory regime. Failures to eradicate H. pylori in young and fit duodenal ulcer patients is the group of patients to whom proximal gastric vagotomy can still be recommended as an elective surgical procedure. The proximal gastric vagotomy should preferably be performed with the laparoscopic technique. Evidence is presented that completeness of vagotomy is of clinical importance. The completeness of vagotomy can be tested and defined.

Entities:  

Mesh:

Year:  1994        PMID: 7502524      PMCID: PMC2588923     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  11 in total

1.  Pyloric and prepyloric ulcers.

Authors:  C Muller; D Liebermann-Meffert; M Allgöwer
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

2.  Release of gastrin by epinephrine in man.

Authors:  F Stadil; J F Rehfeld
Journal:  Gastroenterology       Date:  1973-08       Impact factor: 22.682

3.  Lester R. Dragstedt and his role in the evolution of therapeutic vagotomy in the United States.

Authors:  S J Waisbren; I M Modlin
Journal:  Am J Surg       Date:  1994-03       Impact factor: 2.565

4.  Pitfalls in postoperative testing of the completeness of vagotomy.

Authors:  L Olbe; H Forssell; B Stenquist
Journal:  J Auton Nerv Syst       Date:  1983-10

5.  The Aarhus County Vagotomy Trial: trends in the problem of recurrent ulcer after parietal cell vagotomy and selective gastric vagotomy with drainage.

Authors:  D Andersen; E Amdrup; H Høstrup; F H Sørensen
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

6.  Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.

Authors:  G H Brunner; R Lamberts; W Creutzfeldt
Journal:  Digestion       Date:  1990       Impact factor: 3.216

7.  A criterion for completeness of vagotomy based on basal and vagally stimulated gastric acid secretion after esophagectomy or proximal gastric vagotomy.

Authors:  H Forssell; B Stenquist; L Lundell; L Olbe
Journal:  Scand J Gastroenterol       Date:  1988-06       Impact factor: 2.423

8.  Evidence for the essential role of Helicobacter pylori in gastric ulcer disease.

Authors:  J Labenz; G Börsch
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Role of acid secretory response to sham feeding in predicting recurrent ulceration after proximal gastric vagotomy.

Authors:  B Stenquist; H Forssell; L Olbe; L Lundell
Journal:  Br J Surg       Date:  1994-07       Impact factor: 6.939

10.  Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial.

Authors:  K Lauritsen; B N Andersen; L S Laursen; J Hansen; T Havelund; J Eriksen; J F Rehfeld; J Kjaergaard; J Rask-Madsen
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

View more
  1 in total

1.  Long-term effect of parasympathetic or sympathetic denervation on intestinal epithelial cell proliferation and apoptosis.

Authors:  Elizabeth A Davis; Martha C Washington; Emily R Yaniz; Heidi Phillips; Ayman I Sayegh; Megan J Dailey
Journal:  Exp Biol Med (Maywood)       Date:  2017-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.